Brand Name(s): Florinef Acetate
CAS nº: 127-31-1
(flew droe KOR ti sone)
About Fludrocortisone
This new site is dedicated exclusively to fludrocortisone.
It provides you with the most extensive product information and up-to-date resources regarding this medication, including related news articles, medical studies, an image library and all the necessary information on dosage and side effects.
Whether you are an average consumer or a pharma industry professional, you can now find out everything you need to know about fludrocortisone on this reference site, as well as take part in our open discussion forum by sharing your own knowledge and experience with people who are using this medication.
This unique site will also offer you inside industry news on which companies or organizations are playing an important part in its research, development, production and promotion. It is your one-stop site for a total fludrocortisone experience!
Why is this medication prescribed?
Fludrocortisone is in a class of drugs called steroids. Your body naturally produces steroids similar to this medicine.
This particular medicine is used to treat conditions in which the body does not produce enough of its own steroids, such as in Addison's disease, and salt-losing adrenogenital syndrome.
Latest News
That sinking feeling
Fainting is frightening. Fortunately, it's a one-time thing for most people, brought on by standing...
[more]New Developments in Sepsis
The current definitions and classification for the sepsis syndromes date back to the landmark...
[more]Understanding Addison's Disease -- the Basics
Your body is a finely tuned machine. One way it keeps itself in balance is by using chemical...
[more]Low-Dose Steroids Are Beneficial in Sepsis
(Orlando) — The use of steroids in critically ill patients with sepsis has been both praised and...
[more]Combining Hydrocortisone and Fludrocortisone: An Effective Treatment for Chronic Fatigue Syndrome?
The cause and significance of hypocortisolism in ME/CFS (i.e. decreased production of the hormone...
[more]